About OMNARIS (ciclesonide) Nasal Spray

Enroll in the Relief Is Here Co-pay Program, and you’ll pay only $17 every time you fill your OMNARIS (ciclesonide) prescription — up to 12 times per year.* That's like getting OMNARIS prescription medicine for your nasal allergy symptom relief for the price of a generic!

 

Money Saving Offer

Do you suffer from symptoms of allergic rhinitis, such as sneezing, itchy nose, runny nose, and/or congestion? Qualified patients may be eligible for a reduction in their Rx co-pay for OMNARIS® (ciclesonide) Nasal Spray.

Sign up to save up to $50 on each of your next 12 prescriptions or refills of OMNARIS nasal allergy spray. That’s a savings of up to $600 for the year!*

Pay as low as $17* on EVERY Rx and refill.

To enroll on-line and receive a Relief is Here Co-pay Program e-card, click on "SIGN UP NOW". Please note a valid e-mail address is required to create or activate your Relief Is Here co-pay card online. If you are unwilling or unable to provide this information, you can also enroll or activate your card by calling (866) 278-9738.

If you already have a card and need to activate it, click on “ACTIVATE CARD." If you lost your card or need to reprint your e-card, click on REPRINT CARD,” and you will be asked to enter the email address you used for registration. If you did not register with an email, please call 866-278-9738 to request a replacement card.

      

* Most insured patients will pay no more than $17 monthly with a maximum benefit of $50 per fill. Restrictions apply and co-pay amounts may vary.See program rules and eligibility.

Program Rules: Patient Eligibility, Terms, and Conditions

Valid only for qualified customers with a valid prescription for ZETONNA™ (ciclesonide) Nasal Aerosol or OMNARIS® (ciclesonide) Nasal Spray. No substitutions permitted.

A parent or guardian must enroll in the Relief Is Here Co-pay Program on behalf of a patient under 18 years of age

Not valid for prescriptions covered or paid for by Medicare (including true out-of-pocket expenses under Medicare Part D), Medicaid, or any other federal or state healthcare programs, such as state pharmaceutical assistance programs.

Your discount with the Relief Is Here Co-payProgram card is valid to reduce your co-pay to $17 with a maximum reduction of $50 per prescription. Discount available on up to twelve (12) prescription fills for ZETONNA Nasal Aerosol or OMNARIS Nasal Spray per calendar year.

Your acceptance of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or other third-party payor, and you agree to report acceptance of this offer to your health insurer, health plan, or third-party payor as may be required.

Offer limited to one card per person, and may not be used with any other discount, coupon, or offer.

Only an original Relief Is Here Co-pay Program card or Web-generated paper card will be accepted and must be presented to your pharmacist at the time you have the prescription filled—not valid if reproduced.

Offer valid only in the United States. Void where prohibited by law, taxed, or restricted.

Sunovion Pharmaceuticals Inc. reserves the right to change or discontinue this offer at any time without notice.

By participating in this program, you, the patient, certify that (a) you have read the above terms; (b) you are not reimbursed, nor will you submit a claim for reimbursement, nor will you seek to have any portion of this prescription counted toward your out-of-pocket costs (eg, TrOOP) under any federal, state, or private programs for this or other prescriptions for ZETONNA Nasal Aerosol or OMNARIS Nasal Spray to which this offer will apply; and (c) you will comply with the terms above.

Using mail-order pharmacies

Check with your mail-order pharmacy to see if they accept co-pay cards such as the Relief Is Here Co-pay Program card (most of them do). If they do, all you need to do is submit a photocopy of your card or Web-generated paper card along with your prescription and insurance card information.

For mail-order pharmacies that do not accept co-pay cards, we will reimburse you for the difference so that you are still getting OMNARIS for $17. Visit www.patientrebateonline.com for more information.

Small Font
Medium Font
Large Font

email

print

Considering OMNARIS

Use this interactive checklist to create your own personalized Doctor Discussion Guide.

Create it now

Indication and Dosing

OMNARIS® (ciclesonide) Nasal Spray is for the treatment of nasal allergy symptoms associated with seasonal allergies in adults and children 6 years of age and older, and with year-round allergies in adults and adolescents 12 and older. It is for use in the nose only. OMNARIS is used 1 time each day, 2 sprays per nostril.

Important Safety Information

Do not spray OMNARIS Nasal Spray in your eyes or directly onto your nasal septum (the wall inside your nose between your two nostrils).

OMNARIS Nasal Spray may cause serious side effects, including:

  • nose bleeds and nasal ulcers. Call your healthcare provider right away if you start to have more nose bleeds or nasal ulcers.
  • hole in the cartilage in the nose (nasal septal perforation). Stop using OMNARIS Nasal Spray and call your doctor right away if you have symptoms of a nasal perforation. Symptoms of nasal perforation may include: crusting in the nose, nosebleeds, runny nose, and a whistling sound when you breathe.
  • thrush (Candida), a fungal infection in your nose, mouth, or throat. Tell your healthcare provider if you have any redness or white colored patches in your mouth or throat.
  • slow wound healing. You should not use OMNARIS Nasal Spray until your nose has healed, if you have a sore in your nose, if you have had surgery in your nose, or if your nose has been injured.
  • eye problems such as glaucoma and cataracts. If you have a history of glaucoma or cataracts or have a family history of eye problems, you should have regular eye exams while you use OMNARIS Nasal Spray.
  • immune system problems that may increase your risk of infections. You are more likely to get infections if you take medicines that may weaken your body's ability to fight infections. Avoid contact with people who have contagious diseases such as chicken pox or measles while you use OMNARIS Nasal Spray. Symptoms of an infection may include: fever, pain, aches, chills, feeling tired, nausea, and vomiting.
  • adrenal insufficiency. Adrenal insufficiency is a condition in which the adrenal glands do not make enough steroid hormones. Call your healthcare provider right away if you experience the following symptoms of adrenal insufficiency: tiredness, weakness, dizziness, nausea, and vomiting.
  • slowed or delayed growth in children. A child's growth should be checked regularly while using OMNARIS Nasal Spray.
  • allergic reactions. Call your healthcare provider right away if you experience swelling of the lips, tongue, or throat.

The most common side effects that may occur with OMNARIS Nasal Spray are headache, nosebleed, sore throat and ear pain.

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of OMNARIS Nasal Spray.

For more information, please see the OMNARIS Full Prescribing Information and the OMNARIS Patient Information. You may also call 1-888-394-7377.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.

OMNARIS® (ciclesonide) Nasal Spray is available by prescription. Ask your healthcare professional if OMNARIS Nasal Spray is right for you.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. This site is intended for U.S. residents 18 years of age and older. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

OMNARIS is the registered trademark of Takeda GmbH, used under license. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co. Ltd., is a registered trademark of Dainippon Sumitomo Pharma Co. Ltd.

© 2014 Sunovion Pharmaceuticals Inc. All rights reserved. 03/14 OMN010-14.

Bookmark & Share